However, the criteria used to define risk in various institutional and cooperative groups were disparate, limiting the ability to compare clinical trial results. To mitigate this problem and enhance ...

Please provide your email address to receive an email when new articles are posted on . Determining risk classifications of children with neuroblastoma is “paramount” to optimizing their care, the ...

Panelists discuss how current risk stratification systems, particularly the European Leukemia Net 2022 classification for intensive therapy and the 2024 classification for lower intensity treatments, ...